分子神經變性 SCIE

期刊簡介預計審稿時間： 較慢,6-12周

Molecular Neurodegeneration is an open access, peer-reviewed journal that encompasses all aspects of neurodegeneration research at the molecular and cellular levels.

Neurodegenerative diseases collectively refer to neurological disorders that result from neurodegeneration and include, but are not limited to, Alzheimer's disease, Parkinson's disease, Huntington's disease, and prion diseases. These diseases, which are often associated with advanced aging and display varying degrees of dementia, have become a significant public health issue as humans live longer and the aging population grows larger. Recent advances in the molecular and cellular mechanisms underlying the pathogenesis of these neurodegenerative disorders have allowed for a better understanding of the disease mechanisms.

Molecular Neurodegeneration 是一本開放獲取、同行評審的期刊，涵蓋了分子和細胞層面神經退行性疾病研究的各個方面。

神經退行性疾病統稱由神經退行性疾病引起的神經系統疾病，包括但不限于阿爾茨海默病、帕金森病、亨廷頓病和朊病毒病。這些疾病通常與衰老有關，并表現出不同程度的癡呆癥，隨著人類壽命的延長和老齡化人口的增加，它們已成為一個重大的公共衛生問題。這些神經退行性疾病發病機制背后的分子和細胞機制的最新進展使人們能夠更好地了解疾病機制。

《Molecular Neurodegeneration》(分子神經變性)編輯部通訊方式為BIOMED CENTRAL LTD, 236 GRAYS INN RD, FLOOR 6, LONDON, ENGLAND, WC1X 8HL。如果您需要協助投稿或潤稿服務，您可以咨詢我們的客服老師。我們專注于期刊咨詢服務十年，熟悉發表政策，可為您提供一對一投稿指導，避免您在投稿時頻繁碰壁，節省您的寶貴時間，有效提升發表機率，確保SCI檢索（檢索不了全額退款）。我們視信譽為生命，多方面確保文章安全保密，在任何情況下都不會泄露您的個人信息或稿件內容。